Providers will receive a hardcopy of the updated NSW Immunisation Schedule, NSW Schedule poster (with vaccine images) and fridge basket stickers in the coming weeks. Additional copies can be ordered by completing the NSW Immunisation Resource Order Form.
Restrictions for Shingrix® ordering
NSW Health released a statement on Shingrix® vaccine restrictions to advise that Shingrix will be limited to 5-20 vaccines per month (depending on clinic size) during the initial roll out of the program until early 2024 when supply restrictions are expected to ease. Shingrix® is now available to order through the NSW Vaccine Centre online ordering system.
Prioritisation of Shingrix®
Patients who have previously received Zostavax® must waitat least 5 years after their dose before they are eligible to receive NIP funded Shingrix®.
Prioritise highest risk patients for Shingrix® vaccination – risk of developing shingles increases with age and is higher in people who are immunocompromised.
Zostavax® can be administered to people aged 70 years who prefer to receive this vaccine.
Check vaccination history on AIR and offer any required vaccines at Shingrix® appointment:
Prevenar13® vaccine for people aged 70 years and over
COVID-19 vaccine for people aged 70 years and over if it has been 6 months since last dose/infection
HealthPathways provides health professionals in CESPHN with access to up-to-date clinical information and resources to support assessment, management, and referral of their patients.
For more information visit the Immunisation in Adults pathway:
The CESPHN Vax at Home Service is for those people who are housebound and not able to leave their house to receive a COVID-19 vaccination or booster. The service will accept referrals for people 16 years and over. Referrals will be accepted from GPs and from Local Health Districts. Patient self-referrals will not be accepted.
All referrals must be sent through this Vax at Home Service Online Form. Please also indicate if an influenza vaccine is also required. Please note, a referral will need to be attached to the online form. For further information on the program, please contact us.
Maternal vaccination rates in NSW
A new study has shown that from 2016 to 2020, maternal vaccination increased from 27% to 59% for influenza and from 43% to 79% for pertussis.
While coverage of both maternal influenza and pertussis vaccines has increased over time in NSW, disparities in coverage still exist – younger mothers (aged less than 30 years), those from lower socio-economic status areas and those using the public hospital care model had a lower likelihood of having received maternal influenza and pertussis vaccinations.
Immunisation providers can help to improve maternal vaccine uptake by recommending maternal vaccination and highlighting the benefits and risks associated. Resources are available to support recommended maternal vaccines available under the National Immunisation Program for pregnant women.
About: Learn about the new NIP shingles vaccine Shingrix® which will replace Zostavax® from 1 November 2023. An expert NCIRS panel will be available to answer participants questions live. Date: Tuesday 7 November Time: 12:00pm – 1:00pm
Navigating the new COVID-19 Handbook chapter REGISTER
About: A deep dive into the new chapter of the Australian Immunisation Handbook, exploring the latest COVID-19 guidelines. Date: Wednesday 1 November Time: 7:00pm
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…